Osteoarthritis
News from the FDA/CDC
Arthritis joint pain, inactivity vary greatly across U.S.
The Southeast has the highest rates of adults with severe joint pain and physical inactivity, the CDC reports.
From the Journals
Four biomarkers could distinguish psoriatic arthritis from osteoarthritis
The four-biomarker panel could offer a way to make earlier diagnoses and avoid inappropriate treatment.
Conference Coverage
Industry-funded rheumatology RCTs are higher quality
MAUI, HAWAII – An analysis of 20 years of rheumatology clinical trials.
From the Journals
Disease burden in OA worse than RA 6 months post presentation
RAPID3 scores improved after 6 months for both RA and OA patients, but RA patients saw greater reductions.
From the Journals
Possible mortality risk seen with tramadol in osteoarthritis
Older patients taking tramadol for osteoarthritis had significantly higher mortality risk than did patients taking NSAIDs.
From the Journals
Long-term opioid use substantial in elderly adults prior to total joint replacement
From the Journals
Heberden’s nodes linked to knee OA progression
Progression was associated with periarticular bone area expansion but not osteophyte worsening.
From the Journals
Knee pathologies, including multiple meniscal tears, predict accelerated OA
Longitudinal data suggest a distinct risk factor profile for adults who develop accelerated knee osteoarthritis.
Latest News
Canakinumab reduces arthroplasty rates
CHICAGO – Prespecified secondary analysis from landmark CANTOS trial was the talk of the ACR annual meeting.
From the Journals
A case of cold burn reported with whole-body cryotherapy
A 71-year-old man presented with a cold burn injury a day after a cryotherapy session for back pain and arthritis.
Conference Coverage
Intra-articular Wnt inhibitor for knee OA sails through phase 2
CHICAGO – A single injection brought significant improvement in pain and physical function throughout 6 months of follow-up.